BIOREGENX, INC. Increase (Decrease) in Accounts Payable, Related Parties
BIOREGENX, INC. (BRGX) reported Increase (Decrease) in Accounts Payable, Related Parties of -$98.50 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2026-05-20
- BIOREGENX, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2026-03-31 was -$98.50K, a 37269.43% decline year-over-year.
- BIOREGENX, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2025-12-31 was -$38.02K, a 188.14% decline year-over-year.
- BIOREGENX, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2025-09-30 was $61.40K.
- BIOREGENX, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2025-06-30 was $110.32K, a 639.61% increase year-over-year.
- BIOREGENX, INC. increase (decrease) in accounts payable, related parties for fiscal 2025 was $133.96K, a 1519.43% increase from fiscal 2024.
- BIOREGENX, INC. increase (decrease) in accounts payable, related parties for fiscal 2024 was $8.27K, a 57.13% decline from fiscal 2023.
- BIOREGENX, INC. increase (decrease) in accounts payable, related parties for fiscal 2023 was $19.30K.
| Period end | Increase (Decrease) in Accounts Payable, Related Parties 3 month | Increase (Decrease) in Accounts Payable, Related Parties 6 month | Increase (Decrease) in Accounts Payable, Related Parties 9 month | Increase (Decrease) in Accounts Payable, Related Parties 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$98.50K 10-Q · filed 2026-05-20 | -$136.52K derived: sum of 2 quarters · filed 2026-05-20 | -$75.13K derived: sum of 3 quarters · filed 2026-05-20 | $35.20K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-12-31 | -$38.02K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $23.37K derived: sum of 2 quarters · filed 2026-04-15 | $133.69K derived: sum of 3 quarters · filed 2026-04-15 | $133.96K 10-K · filed 2026-04-15 |
| 2025-09-30 | $61.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $171.72K derived: sum of 2 quarters · filed 2025-11-14 | $171.98K 10-Q · filed 2025-11-14 | $215.13K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-06-30 | $110.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $110.58K 10-Q · filed 2025-08-14 | $153.73K derived: sum of 3 quarters · filed 2026-05-20 | $135.86K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-03-31 | $265.00 10-Q · filed 2026-05-20 | $43.41K derived: sum of 2 quarters · filed 2026-05-20 | $25.54K derived: sum of 3 quarters · filed 2026-05-20 | $40.45K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | $43.14K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $25.27K derived: sum of 2 quarters · filed 2026-04-15 | $40.19K derived: sum of 3 quarters · filed 2026-04-15 | $8.27K 10-K · filed 2026-04-15 |
| 2024-09-30 | -$17.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.95K derived: sum of 2 quarters · filed 2025-11-14 | -$34.87K 10-Q · filed 2025-11-14 | $54.30K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $14.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$17.00K 10-Q · filed 2025-08-14 | $72.17K derived: sum of 3 quarters · filed 2025-08-14 | $65.25K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$31.91K 10-Q · filed 2025-05-15 | $57.25K derived: sum of 2 quarters · filed 2025-05-15 | $50.33K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $89.17K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-04-16 | $82.25K derived: sum of 2 quarters · filed 2025-04-16 | $19.30K 10-K/A · filed 2025-04-16 | |
| 2023-09-30 | -$6.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$69.87K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$62.95K 10-Q · filed 2024-10-09 |